An international team of researchers found that genetic differences result in varying degrees of immune response to the H7N9 influenza virus. By studying immune responses in blood samples from 52 donors, they discovered that differences in a CD8+ T lymphocyte protein complex explained the varying responses. Specifically, those with this protein complex mounted some immune response even to novel flu strains like H7N9, while those without it had no prior immunity and were more at risk. The researchers aim to develop a universal T-cell vaccine to supplement standard flu vaccines and provide protection against H7N9 before the next flu season.